drugset / Trial / NCT05229055

Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK )

NCT05229055

Phase 2/3 Completed 1000 enrolled University of Monastir
RandomizedParallel-groupTriple-blindTreatment

Summary

Pain is the most common complaint for emergency department (ED) visit. Intranasal ketamine has been shown to provide rapid, well-tolerated, effective analgesia to emergency department (ED) patients with acute pain. few trials have studied ketamine infusion subcutaneously for pain management in trauma patients.

Timeline

Start
2023-04-15
Primary completion
2024-05-30
Completion
2025-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 20 mg Intranasal

Indications

No indication recorded.